UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists Journal article
Vergelli C., Schepetkin I.A., Ciciani G., Cilibrizzi A., Crocetti L., Giovannoni M.P., Guerrini G., Iacovone A., Kirpotina L.N., Khlebnikov A.I., Ye R.D., Quinn M.T.. 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists[J]. Bioorganic and Medicinal Chemistry, 2016, 24(11), 2530-2543.
Authors:  Vergelli C.;  Schepetkin I.A.;  Ciciani G.;  Cilibrizzi A.;  Crocetti L.; et al.
Favorite | TC[WOS]:21 TC[Scopus]:21 | Submit date:2018/11/07
Agonist  Ca2++ Mobilization  Formyl Peptide Receptor (Fpr)  Neutrophil  Pyridazin-3(2h)-one  
V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins Journal article
Zhou C., Zhou Y., Wang J., Feng Y., Wang H., Xue J., Chen Y., Ye R.D., Wang M.-W.. V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins[J]. Biochemical Journal, 2013, 451(2), 245-255.
Authors:  Zhou C.;  Zhou Y.;  Wang J.;  Feng Y.;  Wang H.; et al.
Favorite | TC[WOS]:12 TC[Scopus]:14 | Submit date:2018/11/07
Cyclosporin  Formyl Peptide Receptor 1 (Fpr1)  Haplotype  Pharmacogenomics  Receptor Affinity  Single Nucleotide Polymorphism